Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.

Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S.

Eur J Epidemiol. 2013 Aug;28(8):621-47. doi: 10.1007/s10654-013-9825-8. Epub 2013 Jul 31.

2.

Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.

Ziakas PD, Poulou LS, Pavlou M, Zintzaras E.

Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:106-11. doi: 10.1016/j.ejogrb.2015.06.005. Epub 2015 Jun 16. Review.

PMID:
26115054
3.

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.

J Thromb Thrombolysis. 2005 Jun;19(3):189-96.

PMID:
16082606
4.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

5.

Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.

Nishank SS, Singh MP, Yadav R.

Eur J Haematol. 2013 Nov;91(5):462-6. doi: 10.1111/ejh.12190. Epub 2013 Sep 16.

PMID:
23992124
6.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
7.

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.

Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT, Bass EB.

JAMA. 2009 Jun 17;301(23):2472-85. doi: 10.1001/jama.2009.853. Review.

PMID:
19531787
9.

PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.

Pourgheysari B, Boroujeni HR, Hasheminia AM, Drees F.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):471-6. doi: 10.1097/MBC.0b013e32835e4260.

PMID:
23358226
10.

The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.

Gohil R, Peck G, Sharma P.

Thromb Haemost. 2009 Aug;102(2):360-70. doi: 10.1160/TH09-01-0013.

PMID:
19652888
11.
12.

Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.

Aydin H, Gunay M, Celik G, Gunay BO, Aydin UT, Karaman A.

Ophthalmic Genet. 2016 Dec;37(4):415-418. Epub 2016 Mar 28.

PMID:
27018927
13.

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

Bucciarelli P, De Stefano V, Passamonti SM, Tormene D, Legnani C, Rossi E, Castaman G, Simioni P, Cini M, Martinelli I.

Blood. 2013 Oct 10;122(15):2555-61. doi: 10.1182/blood-2013-05-503649. Epub 2013 Aug 2.

14.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.

PMID:
21150787
15.

Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.

Wahba MA, Ismail MA, Saad AA, Habashy DM, Hafeez ZM, Boshnak NH.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):309-15. doi: 10.1097/MBC.0000000000000242.

PMID:
25565385
16.

Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.

Ben Salem-Berrabah O, Fekih-Mrissa N, N'siri B, Ben Hamida A, Benammar-Elgaaied A, Gritli N, Mrissa R.

J Clin Neurosci. 2012 Sep;19(9):1326-7. doi: 10.1016/j.jocn.2011.11.029. Epub 2012 Jun 20.

PMID:
22721898
17.
18.

Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.

Thromb Haemost. 2001 Sep;86(3):809-16. Erratum in: Thromb Haemost 2001 Dec;86(6):1598.

PMID:
11583312
19.

Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.

Chamorro AJ, Marcos M, Hernández-García I, Calvo A, Mejia JC, Cervera R, Espinosa G.

Autoimmun Rev. 2013 Mar;12(5):607-16. doi: 10.1016/j.autrev.2012.11.001. Epub 2012 Nov 30. Review.

PMID:
23207285
20.

Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population.

Pirtskhelani N, Kochiashvili N, Makhaldiani L, Pargalava N, Gaprindashvili E, Kartvelishvili K.

Georgian Med News. 2014 Feb;(227):93-7.

PMID:
24632656

Supplemental Content

Support Center